Market News

The Triumph of Adverum Biotechnologies: Surpassing Analyst Expectations in Q4 2023

by Ron Finklestien

Published On: March 18, 2024 11:06 pm

A Winning Streak: ADVM Stock Shines in Q4 2023

ADVM stock - ADVM Stock Earnings: Adverum Biotechnologies Beats EPS for Q4 2023

Source: iQoncept / Shutterstock

Adverum Biotechnologies (NASDAQ:ADVM) recently unveiled its performance during the final quarter of 2023.

Proving its mettle, Adverum Biotechnologies boasted earnings per share of -23 cents, eclipsing the analyst projection of -34 cents.
However, the period did not witness any reported revenue by the company.

InvestorPlace Earnings, a brainchild utilizing TradeSmith data, now delivers automated updates on quarterly earnings releases. Offering insights on metrics such as earnings per share and revenue, it also appraises companies against analyst forecasts. These updates are swift, devoid of human intervention, to promptly inform our loyal readers. To address concerns or inaccuracies, reach out to us at [email protected].

Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/advm-stock-earnings-adverum-biotechnologies-for-q4-of-2023/.